According to TipRanks.com, Samuel is ranked #4652 out of 5951 analysts.
Currently, the analyst consensus on Health Catalyst is a Strong Buy with an average price target of $48.33.
See today’s analyst top recommended stocks >>
Based on Health Catalyst’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $21.42 million. In comparison, last year the company had a GAAP net loss of $13.58 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Health Catalyst, Inc. provides healthcare data warehousing and process improvement solutions. Its solutions include accountable care, analytics adoption model, care management solutions, healthcare analytics, late-binding data warehouse, population health management, and predictive analytics.
Read More on HCAT:
